Genetic Analysis

Ronny Hermansen, CEO, Genetic Analysis, comments:
“GA is proud to have ELTA90 Group as a partner in the Balkan region and is thrilled to see that our GA-map® platform gets acknowledgement from customers in new markets globally. The GA-map® platform offers a high throughput lab testing platform with an integrated cloud-based software algorithm for immediate result presentation of the microbiome analysis.  As the regulatory requirements in Europe gets stricter, we are happy to see that more and more labs are appreciating our CE-IVD GA-map® solution.”

The market demand for gut microbiome assessments is rapidly increasing globally in the private healthcare services, medical clinics, and academic research with focus on identifying and categorizing the patient’s microbiota. Together with ELTA90, GA can now offer its standardized gut microbiome testing platform to the Balkan countries to meet the growing interest and raise awareness of the impact of microbiota alteration and dysbiosis.

Dr. Theodor Zamfirov, CEO, ELTA90, comments:
“E90 are excited to offer the GA-map® Microbiome testing platform to our Lab customers all over the Balkan region, as we see that the demand for accurate, fast turnaround microbiome testing is increasing rapidly. GA-map® will be a great complementary to our growing business of specialty molecular diagnostics, as several labs in the Balkan countries are focusing on supplying the European market with high quality diagnostics. The core value of ELTA90 is to offer the highest quality products to our customers, and we are proud to add GA-map® to our portfolio of high-end products.”